Form 4: Myriad Genetics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Dale Muzzey, Chief Scientific Officer of Myriad Genetics, sold 452 shares to cover tax obligations related to vesting restricted stock units.
Summary
- On October 9, 2024, Dale Muzzey, the Chief Scientific Officer of Myriad Genetics, sold 452 shares of common stock to cover tax obligations.
- The shares were sold at a price of $24.37 per share.
- Following the transaction, Muzzey directly owns 107,561 shares of Myriad Genetics.
- The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive selling shares to cover taxes is a normal occurrence and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations related to stock awards.
Key Dates
| Date | Description |
|---|---|
| 10/09/2024 | Date of transaction: Dale Muzzey sold 452 shares of Myriad Genetics stock. |
| 10/10/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.